Geospiza and PSC Combine Software and Services to Help Clients Accelerate Development of New Genetic Tests and Personalized Treatments

Business Wire, April 24, 2007

New Clinical Application for Genetic Information Drives Growth Opportunities for Both Companies

SEATTLE & PASADENA, Calif. & AUSTIN, Texas -- Geospiza and Pharmaceutical Services Corporation (PSC) today announced an alliance to deliver software and services to manufacturers of personalized therapies and vaccines based on genetic markers. Under the terms of the agreement, PSC will offer a complete solution of Geospiza software and PSC services to reduce operational costs and regulatory risks for organizations that need to integrate genetic analyses into their manufacturing process.

"Manual genetic analysis continues to be a major bottleneck for companies trying to bring new and innovative genetic tests and personalized treatments to market," said Rob Arnold, president of Geospiza. "Geospiza and PSC are committed to helping our clients manage the regulatory requirements of genetic analysis automation in a full-scale commercial environment."

"We are approaching this market together because the biotech, pharmaceutical and diagnostic industries are at a true inflection point," said Patricia Rossman, Vice President of Pharmaceutical Services Corporation. "PSC and Geospiza share a common vision for delivery excellence."

PSC will target the combined offering to manufacturers of vaccines, novel bio-therapeutics and gene therapies which are regulated by U.S. Food and Drug Administration (FDA) requirements for aseptic processing for the manufacture of sterile drug and biological products under current Good Manufacturing Practice (cGMP) regulations (21 CFR parts 210 and 211). Facilities and agencies involved in environmental monitoring, food safety testing, molecular diagnostic testing and clinical trial efforts will benefit as well.

About Geospiza

Founded in 1997, Geospiza combines deep life science and IT expertise to deliver our clients highly scalable, fully integrated, regulatory-compliant informatics platforms for scaling their laboratory workflow, scientific data management and analytics workflows. The company's customers are primarily molecular diagnostic laboratories, biotechnology and pharmaceutical companies, contract core labs, large research institutes and universities, involved in clinical DNA testing, manufacturing DNA-based bio-therapeutics, delivering sequencing services to outside customers and basic life science research and discovery efforts. More information is available at www.geospiza.com.

About Pharmaceutical Services Corporation

Pharmaceutical Services Corporation is an industry-recognized leader in Validation, Clinical Trials services, and other Quality and Compliance services. Their full-time consulting staff provides a broad range of outsourced services to the biotech, pharmaceutical, medical device and diagnostic industries, from complete turn-key projects to augmenting staff. More information is available at www.biotech.com and www.pscclinical.com.

Geospiza and Finch are registered trademarks of Geospiza. All other trademarks are properties of their respective owners.